Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The function of CXCL9 has not been specifically defined\; however, it is thought to be involved in T cell trafficking. Additionally we are shipping CXCL9 Kits (71) and CXCL9 Proteins (56) and many more products for this protein.
Showing 10 out of 164 products:
Human Monoclonal CXCL9 Primary Antibody for ELISA (Capture), FACS - ABIN4899716
Bronger, Singer, Windmüller, Reuning, Zech, Delbridge, Dorn, Kiechle, Schmalfeldt, Schmitt, Avril: CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. in British journal of cancer 2016
Show all 13 references for 4899716
Human Polyclonal CXCL9 Primary Antibody for IF (p), IHC (p) - ABIN741930
Sawano, Shimizu, Yamada, Nanashima, Miura, Morohashi, Kudo, Hui, Kijima, Hakamada, Tsuchida: Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan. in Oncology reports 2015
Show all 5 references for 741930
Mouse (Murine) Monoclonal CXCL9 Primary Antibody for FACS - ABIN2657882
Helbig, Ruszkiewicz, Lanford, Berzsenyi, Harley, McColl, Beard: Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. in Journal of virology 2008
Show all 4 references for 2657882
Mouse (Murine) Monoclonal CXCL9 Primary Antibody for FACS - ABIN2663670
Thapa, Welner, Pelayo, Carr: CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. in Journal of immunology (Baltimore, Md. : 1950) 2008
Show all 3 references for 2663670
Cow (Bovine) Polyclonal CXCL9 Primary Antibody for WB - ABIN2792191
Egesten, Eliasson, Olin, Erjefält, Bjartell, Sangfelt, Carlson: The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. in International journal of colorectal disease 2007
Show all 2 references for 2792191
Human Monoclonal CXCL9 Primary Antibody for EIA, Func - ABIN115781
Airoldi, Di Carlo, Banelli, Moserle, Cocco, Pezzolo, Sorrentino, Rossi, Romani, Amadori, Pistoia: The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. in The Journal of clinical investigation 2004
Human Polyclonal CXCL9 Primary Antibody for Func, IHC (p) - ABIN2473137
Ciccia, Alessandro, Rizzo, Accardo-Palumbo, Raimondo, Raiata, Guggino, Giardina, De Leo, Sireci, Triolo: Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. in Rheumatology (Oxford, England) 2013
Human Monoclonal CXCL9 Primary Antibody for FACS - ABIN4896556
Mamoni, Blotta: Flow-cytometric analysis of cytokine production in human paracoccidioidomycosis. in Cytokine 2006
CXCL9 expression in lesional macrophages implicates the skin as the source of circulating cytokines. CXCL9 is a promising biomarker of disease activity in morphea.
results support the notion that CXCL9 and CXCL10 (show CXCL10 Antibodies) exert tumour-suppressive function by TIL (show TLR1 Antibodies) recruitment in human ovarian cancer
High CXCL9 plasma levels favour response to pegIFN alpha 2a and ribavirin in hepatitis C virus infected patients regardless of DPP4 (show DPP4 Antibodies) activity.
CXCL9 is a useful predictor of better clinical outcome in colorectal cancer patients.
The mRNA expression and serum levels of CXCL9 were both increased.
Data show that asymptomatic patients with unstable plaques exhibited higher levels of endothelial microparticles (EMPs), CXCL9 chemokine (show CCL1 Antibodies) and stem cell growth factor (show CLEC11A Antibodies); lymphocyte secreted C-type lectin (SCGF (show CLEC11A Antibodies)-beta) compared to those with stable plaques.
congruent with the concept that inflammation plays a key role in the pathogenesis of LV dysfunction, MIG, IP10 (show CXCL10 Antibodies) and I-TAC (show CXCL11 Antibodies) add diagnostic accuracy over and beyond NT-pro BNP (show BNC2 Antibodies).
Suggest that CD44 (show CD44 Antibodies) and CXCL9 may serve as predictive biomarkers to identify liver allograft recipients at risk for clinically significant acute graft rejection.
Knock-down of CD44 (show CD44 Antibodies) resulted in an upregulation of mRNA expression of the chemokines CXCL9 and CXCL12 (show CXCL12 Antibodies), as well as their receptors CXCR3 (show CXCR3 Antibodies) and CXCR4 (show CXCR4 Antibodies).
There were no significant differences in distribution of CXCL9 genotypes and alleles between rheumatoid arthritis patients and control group.
This report describes the cloning and characterization of expressed gene sequences of bovine, equine, and swine CXCL9 from RNA obtained from peripheral blood mononuclear cells and other tissues.
CXCK9 and CXCL10 (show CXCL10 Antibodies) chemokines displayed a trend of decreasing mRNA expression as lesion progressed, suggesting a higher level of importance during the early stages of the immune response to mycobacterial infection.
IFNalphaR1 signaling promoted CXCL9 and CXCL10 (show CXCL10 Antibodies) synthesis, suggesting that these chemokines might be involved in the LPS (show TLR4 Antibodies) and CD134 (show TNFRSF4 Antibodies) costimulation response.
CXCL10 (show CXCL10 Antibodies) plays in the pathogenesis of recurrent Herpetic stromal keratitis, and that CXCL9 displays its importance when CXCL10 (show CXCL10 Antibodies) is absent.
CXCL9 expression is strongly upregulated in PGRN (show GRN Antibodies) KO mice and its level is correlated with severity of inflammation in a dermatitis model.
hepatic expression of the inflammatory CXC chemokine (show CXCL12 Antibodies) ligands (CXCL)9 and CXCL10 (show CXCL10 Antibodies) strongly increased whereas homeostatic CXCL12 (show CXCL12 Antibodies) significantly decreased.
Here, we report the evidence for the production of MIG, a second CXCR3 (show CXCR3 Antibodies) ligand, during the primary immune response to HSV-1 corneal infection.
These findings identify a novel role for the immune cell-derived CXCL9 chemokine (show CCL1 Antibodies) in directing a protective antimicrobial response in the intestinal mucosa.
These results indicate that CXCL9 is crucial for recruiting immune T cells into the brain and inducing an accumulation of the T cells into the areas where tachyzoites proliferate to prevent reactivation of chronic T. gondii infection.
tumours are characterized by expression of inflammatory chemokines (CCL2 (show CCL2 Antibodies), CCL5 (show CCL5 Antibodies), CCL7 (show CCL7 Antibodies), CCL8 (show CCL8 Antibodies), CCL12 (show Ccl12 Antibodies), CXCL9, CXCL10 (show CXCL10 Antibodies) and CX3CL1 (show CX3CL1 Antibodies)), reflected by an enrichment of activated Foxp3 (show FOXP3 Antibodies)(-) and Foxp3 (show FOXP3 Antibodies)(+) T cells
Data show that testosterone treatment of female mice significantly reduced the expression of interleukin 17A (IL-17A (show IL17A Antibodies)), chemokines CXCL-9 and CXCL-10 (show CXCL10 Antibodies) within the liver.
Aged mice had similar levels of IL-1beta (show IL1B Antibodies), TNF (show TNF Antibodies), IFN-gamma (show IFNG Antibodies), IL-17 (show IL17A Antibodies), and granulocyte colony-stimulating factor (show CSF3 Antibodies) following S. pneumoniae infection, compared with young mice, but increased levels of the chemokines CXCL9, CXCL12 (show CXCL12 Antibodies), CCL3 (show CCL3 Antibodies), CCL4 (show CCL4 Antibodies), CCL5 (show CCL5 Antibodies), CCL11 (show CCL11 Antibodies), and CCL17 (show CCL17 Antibodies).
The function of this gene has not been specifically defined\; however, it is thought to be involved in T cell trafficking. This gene has been localized to 4q21 with INP10, which is also a member of the chemokine family of cytokines.
C-X-C motif chemokine 9
, gamma-interferon-induced monokine
, monokine induced by gamma interferon
, monokine induced by interferon-gamma
, small-inducible cytokine B9
, monokine induced by interferon gamma
, gamma interferon-induced monokine
, protein m119
, small inducible cytokine B subfamily (Cys-X-Cys), member 9
, small inducible cytokine B9